Skip to content
Screener

EyePoint, Inc. EYPT Free cash flow

Free cash flow at other companies

Merck & Co. logo
Merck & Co.MRK
$4.48B+77.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$572.8M-38.1%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$70.66M-51.6%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
-$40.95M-39.5%
Regenxbio logo
RegenxbioRGNX
-$63M-26.7%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
-$68.13M-40.8%

Other financials

Income statement

See full
Revenue$507.0K-90.5%
Gross profit$9.8M-30.1%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%

Valuation

See full
Market cap$1.11B+51.9%
Enterprise value$1.02B+49.6%
P/S396.6×+383×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Where this comes from

Calculated from EyePoint, Inc.’s reported figures.

The source filing: EyePoint, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335037

FAQ

What is EyePoint, Inc.'s free cash flow?
EyePoint, Inc. (EYPT) reported free cash flow of -$63.55M in Q2 2026.
How has EyePoint, Inc.'s free cash flow changed year-over-year?
EyePoint, Inc.'s free cash flow increased by 0.4% year-over-year, from -$63.81M to -$63.55M.
What is the long-term trend for EyePoint, Inc.'s free cash flow?
Over 4 years (2021 to 2025), EyePoint, Inc.'s free cash flow has grown at a 48.3% compound annual growth rate (CAGR), from -$50.25M to -$243.39M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about EyePoint, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude